Evolution of the Average Target: Danaher Corporation

Evolution of the Target Price: Danaher Corporation

Changes in Analyst Recommendations: Danaher Corporation

42f10cd006606b8f1962af7ea2e1.-1jY87c5DSNT-Icldv4CtObu5tsZnkQgxUY5pgKyqfY.qwmvvsBUQhs3lMFHIZA0_5CWk74g6D54vzYL5Xjl9qKcabuw6HNhVRud3g~1c63095d0f3d11a33a58d3b74477acaa
09-09 Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says MT
09-03 Baird Adjusts Price Target on Danaher to $238 From $232, Keeps Outperform Rating MT
09-01 HSBC Adjusts Price Target on Danaher to $250 From $230, Maintains Buy Rating MT
07-22 Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says MT
07-22 Deutsche Bank Adjusts Danaher Price Target to $240 From $250, Maintains Buy Rating MT
07-22 Morgan Stanley Adjusts Price Target on Danaher to $220 From $255, Maintains Overweight Rating MT
07-22 Wells Fargo Adjusts Price Target on Danaher to $195 From $212, Maintains Equalweight Rating MT
07-22 Stifel Adjusts Price Target on Danaher to $220 From $260, Maintains Buy Rating MT
07-22 Jefferies Adjusts Price Target on Danaher to $210 From $245, Maintains Buy Rating MT
07-22 Guggenheim Adjusts Price Target on Danaher to $200 From $235, Maintains Buy Rating MT
07-22 TD Cowen Adjusts Price Target on Danaher to $236 From $240, Maintains Buy Rating MT
07-22 Goldman Sachs Adjusts Price Target on Danaher to $210 From $230, Maintains Buy Rating MT
07-22 Leerink Partners Adjusts Price Target on Danaher to $240 From $270, Maintains Outperform Rating MT
07-21 RBC Raises Danaher Price Target to $215 From $200 MT
07-21 Evercore ISI Adjusts Price Target on Danaher to $205 From $230 MT
07-13 Baird Adjusts Price Target on Danaher to $251 From $245, Maintains Outperform Rating MT
07-06 Evercore ISI Adjusts Price Target on Danaher to $230 From $232 MT
06-03 HSBC Adjusts Price Target on Danaher to $230 From $270, Maintains Buy Rating MT
05-15 Danaher Seen on Path to Growth Reacceleration on Bioprocess Recovery, RBC Says MT
05-15 Danaher Set for Growth Reacceleration Amid Strong Bioprocessing Trends, RBC Says MT
04-24 Argus Adjusts Price Target on Danaher to $230 From $265, Maintains Buy Rating MT
04-22 Morgan Stanley Cuts Price Target on Danaher to $255 From $270 MT
04-22 UBS Cuts Price Target on Danaher to $250 From $270, Maintains Buy Rating MT
04-22 Jefferies Adjusts Price Target on Danaher to $245 From $240, Maintains Buy Rating MT
04-22 Guggenheim Adjusts Price Target on Danaher to $235 From $275, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.46%
+5.79%
+29.04%
+45.22%
+19.07%
+19.67%
+19.07%
+8.42%
+12.9%
-1.84%
Average +17.18%
Weighted average by Cap. +16.63%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
200.14USD
Average target price
229.09USD
Spread / Average Target
+14.46%
High Price Target
310.00USD
Spread / Highest target
+54.89%
Low Price Target
195.00USD
Spread / Lowest Target
-2.57%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. DHR Stock
  4. Consensus Danaher Corporation
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!